Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Petunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
Petunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
CAS No. 1644557-67-4
Petunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside( ——— )
Catalog No. M39769 CAS No. 1644557-67-4
Petunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePetunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPetunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
-
DescriptionPetunidin3-Rutinoside(Cis-p-coumarin)glucoside-5-glucoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1644557-67-4
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PACAP (6-38), human,...
PACAP (6-38), human, ovine, rat TFA is a potent PACAP receptor antagonist with IC50s of 30, 600, and 40 nM for PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2, respectively.
-
CGGRGD
CGGRGD is a RGD derivative with cysteine as the n-terminal. CGGRGD was synthesized by solid phase peptide synthesis technology, and amino2-cyanobenzothiazole (2-cyanobenzothiazole) (2-cyanobenzothiazole (CBT) was added on the surface of PCL fiber for ammoniation.
-
(5R)-5-hydroxy-7-(4-...
Antiviral agent 41 (compound 5) is a diarylheptanoid isolated from Alpinia officinarum. Antiviral agent 41 exhibits potential antiviral activity against influenza virus in vitro.
